CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-17 | Anicetti Vincent R Chief Operating Officer | Sale | −5,000 | $19.56 | $98K | 57,996 |
| 2020-01-17 | Anicetti Vincent R Chief Operating Officer | Option exercise | +2,500 | $12.70 | $32K | 60,496 |
| 2020-01-17 | Anicetti Vincent R Chief Operating Officer | Sale | −2,500 | $19.69 | $49K | 57,996 |
| 2020-01-17 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −2,500 | 32,488 | ||
| 2020-01-17 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −2,500 | 47,500 | ||
| 2020-01-15 | Viret Jean-Frederic Chief Financial Officer | Option exercise | +6,318 | $10.05 | $63K | 53,159 |
| 2020-01-15 | Viret Jean-Frederic Chief Financial Officer | Sale | −3,520 | $19.67 | $69K | 49,639 |
| 2020-01-15 | Viret Jean-Frederic Chief Financial Officer | Sale | −2,798 | $20.08 | $56K | 46,841 |
| 2020-01-15 | Viret Jean-Frederic Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −6,318 | 104,728 | ||
| 2020-01-12 | HEALY JAMES Director | Option exercise | +20,000 | $12.37 | $247K | 70,086 |
| 2020-01-12 | HEALY JAMES Director | Option exercise · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2020-01-10 | Satvat Ali J. Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-01-10 | Szela Mary T Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-01-10 | Wahlstrom Mats Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-01-10 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-01-10 | LAWLIS V BRYAN Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-01-10 | Richards Christos Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-01-10 | NUSSBAUM SAMUEL R MD Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-01-10 | Lanfear Dennis M President & CEO | Grant or award | +59,763 | 184,780 | ||
| 2020-01-10 | Lanfear Dennis M President & CEO | Shares withheld for taxes | −21,516 | $17.73 | $381K | 163,264 |
Page 17 of 39 · 768 trades